# Restart Life Sciences Corp. (NMLSF)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NMLSF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -1.39M | $ -638.4K | $ 245.4K | $ 1.29M |
| 2024 | $ 0 | $ 229.0K | $ -73.1K | $ 79.9K | $ -299.1K |
| 2023 | $ 0 | $ -1.27M | $ -288.0K | $ 0 | $ -810.6K |
| 2022 | $ 0 | $ -2.65M | $ -1.55M | $ 0 | $ 41.3K |
| 2021 | $ 0 | $ -3.06M | $ -2.22M | $ 0 | $ 459.1K |
| 2020 | $ 13.7K | $ -27.79M | $ -1.02M | $ 0 | $ 4.71M |
| 2019 | $ 8.7K | $ -1.68M | $ -1.06M | $ 0 | $ 6.26M |
| 2018 | $ 0 | $ -4.40M | $ -1.74M | $ 0 | $ 7.24M |
| 2017 | $ 0 | $ -2.34M | $ -1.90M | $ 0 | $ 3.07M |
| 2016 | $ 0 | $ -2.65M | $ -981.7K | $ 0 | $ 653.4K |
| 2015 | $ 0 | $ -894.8K | $ -918.6K | $ 0 | $ 199.3K |
| 2014 | $ 0 | $ -2.72M | $ -646.2K | $ 0 | $ 126.8K |
| 2013 | $ 0 | $ -352.5K | $ -205.2K | $ 0 | $ 1.28M |
| 2012 | $ 0 | $ -8.94M | $ -401.2K | $ 0 | $ 1.35M |
| 2011 | $ 0 | $ -4.53M | $ -3.05M | $ 0 | $ 7.92M |
| 2010 | $ 0 | $ -3.55M | $ -1.09M | $ 0 | $ 2.88M |
| 2009 | $ 0 | $ -2.55M | $ -3.56M | $ 0 | $ 4.11M |
| 2008 | $ 0 | $ -733.1K | $ -975.1K | $ 0 | $ 1.85M |
| 2007 | $ 13.5K | $ -757.0K | $ -1.69M | $ 0 | $ 1.60M |
| 2006 | $ 886 | $ -131.2K | $ -478.8K | $ 0 | $ 625.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.19 |
| Liabilities / Eq | 0.37 |
| Current Ratio | 3.67 |

## Other views

- [Metrics](https://sponda.capital/en/NMLSF.md)
- [Charts](https://sponda.capital/en/NMLSF/charts.md)
- [Compare](https://sponda.capital/en/NMLSF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.